Search research articles
Contact Us
Filters
Showing results (161-170 of 176) with videos related to
Page
of 18
Sort By:
Journal of Palliative Medicine
|
March 29, 2020
Characteristics and Impact of Post-Transplant Interdisciplinary Palliative Care Consultation in Older Allogeneic Hematopoietic Cell Transplant Recipients
Richard J Lin, Abigail G Cohen, Stacy M Stabler, et al.
Leukemia & Lymphoma
|
September 3, 2021
Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant
Jan Philipp Bewersdorf, Andriy Derkach, Lohith Gowda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 27, 2021
National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide
Bronwen E Shaw, Antonio Martin Jimenez-Jimenez, Linda J Burns, et al.
Blood Advances
|
June 12, 2025
Bone marrow and blood demonstrate distinct immune reconstitution patterns and correlations with relapse post-transplant
Susan DeWolf, Jason Kuttiyara, Paola Vinci, et al.
Transplantation and Cellular Therapy
|
March 17, 2021
Cellular Therapy During COVID-19: Lessons Learned and Preparing for Subsequent Waves
Mariam T Nawas, Gunjan L Shah, Darren R Feldman, et al.
The New England Journal of Medicine
|
June 21, 2023
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis
Javier Bolaños-Meade, Mehdi Hamadani, Juan Wu, et al.
Blood Advances
|
April 30, 2025
Impact of Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis in Patients 70 years and Older: An Update from BMT CTN 1703
Sameem M Abedin, Michael J Martens, Javier Bolaños-Meade, et al.
Blood
|
August 27, 2025
CD371-Targeted CAR T cells Secreting Interleukin-18 Exhibit Robust Expansion and Clear Refractory Acute Myeloid Leukemia
Mark B Geyer, Susan DeWolf, Xiaoli Mi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 3, 2025
Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703
Shernan G Holtan, Javier Bolaños-Meade, Monzr M Al Malki, et al.
American Journal of Hematology
|
October 17, 2022
Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia
Maximilian Stahl, Andriy Derkach, Noushin Farnoud, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 176) with videos related to
Sort By:
Page
of 18
Journal of Palliative Medicine
|
March 29, 2020
Characteristics and Impact of Post-Transplant Interdisciplinary Palliative Care Consultation in Older Allogeneic Hematopoietic Cell Transplant Recipients
Richard J Lin, Abigail G Cohen, Stacy M Stabler, et al.
Leukemia & Lymphoma
|
September 3, 2021
Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant
Jan Philipp Bewersdorf, Andriy Derkach, Lohith Gowda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 27, 2021
National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide
Bronwen E Shaw, Antonio Martin Jimenez-Jimenez, Linda J Burns, et al.
Blood Advances
|
June 12, 2025
Bone marrow and blood demonstrate distinct immune reconstitution patterns and correlations with relapse post-transplant
Susan DeWolf, Jason Kuttiyara, Paola Vinci, et al.
Transplantation and Cellular Therapy
|
March 17, 2021
Cellular Therapy During COVID-19: Lessons Learned and Preparing for Subsequent Waves
Mariam T Nawas, Gunjan L Shah, Darren R Feldman, et al.
The New England Journal of Medicine
|
June 21, 2023
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis
Javier Bolaños-Meade, Mehdi Hamadani, Juan Wu, et al.
Blood Advances
|
April 30, 2025
Impact of Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis in Patients 70 years and Older: An Update from BMT CTN 1703
Sameem M Abedin, Michael J Martens, Javier Bolaños-Meade, et al.
Blood
|
August 27, 2025
CD371-Targeted CAR T cells Secreting Interleukin-18 Exhibit Robust Expansion and Clear Refractory Acute Myeloid Leukemia
Mark B Geyer, Susan DeWolf, Xiaoli Mi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 3, 2025
Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703
Shernan G Holtan, Javier Bolaños-Meade, Monzr M Al Malki, et al.
American Journal of Hematology
|
October 17, 2022
Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia
Maximilian Stahl, Andriy Derkach, Noushin Farnoud, et al.
Page
of 18